Raymond James Financial Inc Apellis Pharmaceuticals, Inc. Transaction History
Raymond James Financial Inc
- $264 Billion
- Q4 2024
A detailed history of Raymond James Financial Inc transactions in Apellis Pharmaceuticals, Inc. stock. As of the latest transaction made, Raymond James Financial Inc holds 49,015 shares of APLS stock, worth $1.48 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
49,015Holding current value
$1.48 Million% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding APLS
# of Institutions
304Shares Held
112MCall Options Held
3.85MPut Options Held
1.09M-
Wellington Management Group LLP Boston, MA15.6MShares$470 Million0.08% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA11.9MShares$359 Million14.88% of portfolio
-
Avoro Capital Advisors LLC New York, NY11.1MShares$336 Million4.82% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.82MShares$296 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.8MShares$175 Million0.01% of portfolio
About Apellis Pharmaceuticals, Inc.
- Ticker APLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 109,865,000
- Market Cap $3.32B
- Description
- Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...